
There is little information on how target zzso levels can be achieved in end stage zzso disease zzso patients in a zzso multidisciplinary zzso 

We zzso reviewed a zzso zzso management program for chronic zzso zzso zzso All 26 adult patients on chronic HD at a zzso care medical facility were entered into the zzso A clinical pharmacist was responsible for laboratory monitoring, patient counseling, and the initiation and dosage adjustment of an appropriate zzso A zzso zzso inhibitor zzso using a dosing zzso and monitoring zzso The zzso zzso zzso cholesterol goal was zzso 100 zzso A zzso zzso provided nutrition counseling and the zzso was notified of potential or existing drug interactions or adverse drug reactions zzso Patients received a zzso containing zzso panel results to encourage zzso Data was collected at program initiation and for 6 months zzso 

At the start of the program, zzso of patients were at target LDL zzso At 6 months, zzso had achieved target LDL zzso zzso zzso Mean LDL cholesterol decreased from 96 zzso 5 to 80 zzso 3 zzso zzso zzso zzso and mean total cholesterol decreased from 170 zzso 7 to 151 zzso 4 zzso zzso zzso zzso Fifteen adjustments in drug therapy were zzso Eight adverse drug reactions were zzso 2 required drug zzso or an alternative zzso Physicians were alerted to 8 potential zzso zzso and appropriate monitoring was zzso 

Our findings demonstrate both feasibility and efficacy of a multidisciplinary approach in management of zzso in HD zzso 

